Chronic Obstructive Pulmonary Disease (COPD) Treatment Market is Predicted to Expand at a CAGR of 4.4% during the Forecast Period, notes TMR Study

News provided by

Jul 07, 2022, 09:30 ET

Rise in the prevalence of COPD disease is necessitating more COPD care, which is expected to drive the global market during the forecast period
Regulatory approvals and an increase in combination therapy's positive outcome in treating COPD have accelerated its uptake, which is likely to drive the market in the forthcoming years

WILMINGTON, Del., July 7, 2022 /PRNewswire/ -- The value of the global chronic obstructive pulmonary disease (COPD) treatment market was clocked at US$ 19.8 Bn in 2021. The global market is anticipated to rise at a CAGR of 4.4% during the forecast period, from 2022 to 2031. The global market is likely to attain value of more than US$ 30.4 Bn by 2031. The global chronic obstructive pulmonary disease treatment market is being driven by risk factors such as exposure to environmental and direct tobacco smoke, allergens (such as animal dander, dust mites, ragweed, or pollen), toxic substances in the air (such as smoke, chemical fumes, or strong odors), and extreme weather conditions. There has been an increasing awareness about COPD prevention as well.

Risk factors like occupational dusts and chemicals (caused by irritants, vapors, and fumes), outdoor air pollution, indoor air pollution, and recurring lower respiratory infections in children are likely to drive demand COPD treatment. In order to generate profitable revenue streams, market players are concentrating on developing high-end products, which are expected to work for all COPD types. Companies in the global chronic obstructive pulmonary disease (COPD) treatment market is likely to observe an increase in opportunity due to the rising usage of triple therapy treatment and digital inhalers options.

Globally high COPD incidence and a strong pipeline of COPD therapy medications are expected to drive demand for COPD treatment throughout the projection period. The global market is expected to grow quickly due to the rising elderly populace, early COPD diagnosis due to growing awareness, and unhealthy lifestyle trends across all age groups.

Request Brochure of Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Research Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=73763

Key Findings of Market Report

The burden and occurrence of chronic obstructive pulmonary disease (COPD) are anticipated to rise in the near future as a result of continuous exposure to COPD risk factors and rapid aging of global population, as per a study by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) in 2022. As such, the market for chronic obstructive pulmonary disease treatment is expected to increase in the near future.
Depending on distribution channel, the category of retail pharmacies is predicted to have a significant proportion of the global market. Due to the rise in retail pharmacies in developing countries and the number of COPD treatments being prescribed through them, the category is anticipated to expand quickly throughout the projection period.
Market participants are expected to witness high growth prospects in the Asia Pacific. The regional market is being driven by a high incidence of the condition, an aging population, a spike in the patient populace, and expansion of the healthcare industry.

Request for Analysis of COVID-19 Impact on Chronic Obstructive Pulmonary Disease (COPD) Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=73763

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: Growth Drivers

The global chronic obstructive pulmonary disease treatment market is anticipated to grow due to an increase in the number of patients who are effectively treated with combination therapy but did not improve with corticosteroid or bronchodilators therapies. For treating the symptoms as well as improving the quality of life of such patients, combination treatment is superior than monotherapy.
In 2021, the market for treating chronic obstructive pulmonary disease (COPD) was dominated by North America, which held a share of almost 40%. From 2022 to 2031, the regional market is anticipated to expand at a CAGR of 4.3%. This can be attributed to the highly structured and technologically advanced regional healthcare sector and the presence of both commercial and state health insurance companies with clearly defined reimbursement procedures.

Get Exclusive PDF Sample Copy of Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=73763

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: Key Players

Some of the key market players are

Sunovion Pharmaceuticals, Inc.
Boehringer Ingelheim International GmbH
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Kyowa Hakko Kirin
CHIESI Farmaceutici S.p.A.

Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=73763

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market: Segmentation

Drug Class

Combination Therapy
Bronchodilators
Corticosteroids
Phosphodiesterase Type 4 Inhibitor
Mucokinetics
Others

Type

Chronic Bronchitis
Emphysema

Drug Class

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Brachytherapy Devices Market: The brachytherapy applicators segment is estimated to expand at a CAGR of 8.4% and account for the dominant share of the brachytherapy devices market during the forecast period.

Hyperbaric Oxygen Therapy Devices Market: The global hyperbaric oxygen therapy devices market is expected to reach the value of US$ 7.3 Bn by the end of 2028.

IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market: The global IBD (ulcerative colitis and Crohn's disease) treatment market was valued at ~US$ 15.5 Bn in 2018 and is projected to expand at a CAGR of ~6% from 2019 to 2027.

Hemophilia Treatment Drugs Market: The global hemophilia treatment drugs market was valued at US$ 9,500 Mn in 2017 and is anticipated to reach US$ 15,000 Mn by 2026, expanding at a CAGR of 5% from 2018 to 2026.

Critical Limb Ischemia Treatment Market: The global critical limb ischemia treatment market is driven by rise in prevalence of critical limb ischemia. Growth of the market is also attributed to increase in awareness about critical limb ischemia and rich product pipeline.

Menopausal Hot Flashes Treatment Market: Growing population of elderly women worldwide coupled with rise in menopausal hot flashes symptoms is a major factor responsible for the growth of global menopausal hot flashes treatment market.

Substance Abuse Treatment Market: The global substance abuse treatment market is anticipated to cross US$ 23.1 Bn by 2031. The global market is projected to grow at a CAGR of 8.5% from 2022 to 2031.

Glioblastoma Multiforme Treatment (GBM) Market: The global glioblastoma multiforme (GBM) treatment market is expected to reach the value of US$ 3.72 Bn by the end of 2028.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and business consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]